← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #917 OF 1,000 MOST-CITED

Written procedures lacking for use of pesticides etc.

FDA cited this observation 15 times across 15 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs15
BY FISCAL YEAR
FY20251
FY20241
FY20231
FY20223
FY20201
FY20194
FY20182
FY20172

How FDA worded it — real examples

Written procedures are lacking for the use of designed to prevent the contamination of.

EPM Packaging, Inc. · Lexington, Nebraska · Drugs · 2025-06-13

Written procedures are lacking for the use of cleaning and sanitizing agents designed to prevent the contamination of equipment.

Vitti Labs, LLC · Liberty, Missouri · Drugs · 2024-03-15

Written procedures are lacking for the use of cleaning and sanitizing agents designed to prevent the contamination of components, drug product containers, closures and packaging, labeling materials.

Corium Innovations, Inc. · Grand Rapids, Michigan · Drugs · 2022-11-18

Written procedures are lacking for the use of cleaning and sanitizing agents designed to prevent the contamination of equipment.

Qualgen, LLC · Edmond, Oklahoma · Drugs · 2022-09-30

Written procedures are lacking for the use of cleaning and sanitizing agents designed to prevent the contamination of equipment, components, drug product containers, closures and drug products.

Kimera Labs Inc · Miramar, Florida · Drugs · 2022-07-21

Written procedures are lacking for the use of rodenticides, insecticides, fungicides and cleaning and sanitizing agents designed to prevent the contamination of equipment, components and drug products.

PREMIER NUTRA PHARMA Inc. · Carlsbad, California · Drugs · 2022-07-08

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Contamination controlPharmaceutical quality systemPharma industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →